A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network

Peer Review reports

Original Submission
28 Jul 2022	Submitted	Original manuscript
27 Aug 2022	Reviewed	Reviewer Report - Kirsty Loudon
22 Sep 2022	Author responded	Author comments - Julia Maria Neuhann
Resubmission - Version 2
22 Sep 2022	Submitted	Manuscript version 2
Publishing
26 Sep 2022	Editorially accepted
8 Oct 2022	Article published	10.1186/s13063-022-06791-y

Back to article page